Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Collett

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Alimentary Pharmacology & Therapeutics|August 28, 2003
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel diseaseR B Gearry, M L Barclay, M J Burt, et al.
The New Zealand Medical Journal|March 22, 1995
Treatment of chronic hepatitis C with interferon alphaA G Ross, M J Burt, L C Jennings, et al.
The Medical Journal of Australia|October 6, 2001
High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening?C J Hovell, J A Collett, G Vautier, et al.
The New Zealand Medical Journal|September 24, 1999
Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studiesJ A Collett, M J Burt, C M Frampton, et al.
Gut|November 21, 1998
The significance of haemochromatosis gene mutations in the general population: implications for screeningM J Burt, P M George, J D Upton, et al.
The New Zealand Medical Journal|November 4, 2000
The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch communityB A Chapman, M J Burt, C M Frampton, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Alimentary Pharmacology & Therapeutics|August 28, 2003
Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel diseaseR B Gearry, M L Barclay, M J Burt, et al.
The New Zealand Medical Journal|March 22, 1995
Treatment of chronic hepatitis C with interferon alphaA G Ross, M J Burt, L C Jennings, et al.
The Medical Journal of Australia|October 6, 2001
High prevalence of coeliac disease in a population-based study from Western Australia: a case for screening?C J Hovell, J A Collett, G Vautier, et al.
The New Zealand Medical Journal|September 24, 1999
Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studiesJ A Collett, M J Burt, C M Frampton, et al.
Gut|November 21, 1998
The significance of haemochromatosis gene mutations in the general population: implications for screeningM J Burt, P M George, J D Upton, et al.
The New Zealand Medical Journal|November 4, 2000
The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch communityB A Chapman, M J Burt, C M Frampton, et al.
Pageof 2